The expression of methyltransferase-like 3 (METTL3) is increased through SUMO1 SUMOylation modification in colorectal cancer, and increased METTL3 promotes the expression of ABCC1 protein, thus leading to drug resistance of colorectal cancer cells to chemotherapy [28]. This evidence concerns the gene ABCC1 and colorectal cancer.